PetMed Express (NASDAQ:PETS) Posts Earnings Results, Misses Estimates By $0.02 EPS

PetMed Express (NASDAQ:PETS) posted its quarterly earnings results on Monday. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.02), RTT News reports. PetMed Express had a negative return on equity of 1.00% and a negative net margin of 0.37%.

PetMed Express Price Performance

Shares of NASDAQ PETS opened at $5.27 on Tuesday. PetMed Express has a 52 week low of $2.90 and a 52 week high of $6.85. The company’s 50-day moving average price is $5.13 and its 200 day moving average price is $4.31.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of PetMed Express from a “hold” rating to a “buy” rating in a research note on Tuesday, November 12th.

Insiders Place Their Bets

In other news, Director Leslie C.G. Campbell purchased 15,000 shares of the firm’s stock in a transaction on Wednesday, December 4th. The shares were bought at an average cost of $5.38 per share, with a total value of $80,700.00. Following the purchase, the director now directly owns 70,000 shares of the company’s stock, valued at approximately $376,600. This trade represents a 27.27 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.10% of the stock is owned by corporate insiders.

PetMed Express Company Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.